» Articles » PMID: 28362237

Ionizing Radiation Augments Glioma Tropism of Mesenchymal Stem Cells

Overview
Journal J Neurosurg
Specialty Neurosurgery
Date 2017 Apr 1
PMID 28362237
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

OBJECTIVE Mesenchymal stem cells (MSCs) have been shown to localize to gliomas after intravascular delivery. Because these cells home to areas of tissue injury, the authors hypothesized that the administration of ionizing radiation (IR) to tumor would enhance the tropism of MSCs to gliomas. Additionally, they sought to identify which radiation-induced factors might attract MSCs. METHODS To assess the effect of IR on MSC migration in vitro, transwell assays using conditioned medium (CM) from an irradiated commercially available glioma cell line (U87) and from irradiated patient-derived glioma stem-like cells (GSCs; GSC7-2 and GSC11) were employed. For in vivo testing, green fluorescent protein (GFP)-labeled MSCs were injected into the carotid artery of nude mice harboring orthotopic U87, GSC7-2, or GSC17 xenografts that were treated with either 0 or 10 Gy of IR, and brain sections were quantitatively analyzed by immunofluorescence for GFP-positive cells. These GSCs were used because GSC7-2 is a weak attractor of MSCs at baseline, whereas GSC17 is a strong attractor. To determine the factors implicated in IR-induced tropism, CM from irradiated GSC7-2 and from GSC11 was assayed with a cytokine array and quantitative ELISA. RESULTS Transwell migration assays revealed statistically significant enhanced MSC migration to CM from irradiated U87, GSC7-2, and GSC11 compared with nonirradiated controls and in a dose-dependent manner. After their intravascular delivery into nude mice harboring orthotopic gliomas, MSCs engrafted more successfully in irradiated U87 (p = 0.036), compared with nonirradiated controls. IR also significantly increased the tropism of MSCs to GSC7-2 xenografts (p = 0.043), which are known to attract MSCs only poorly at baseline (weak-attractor GSCs). Ionizing radiation also increased the engraftment of MSCs in strong-attractor GSC17 xenografts, but these increases did not reach statistical significance. The chemokine CCL2 was released by GSC7-2 and GSC11 after irradiation in a dose-dependent manner and mediated in vitro transwell migration of MSCs. Immunohistochemistry revealed increased CCL2 in irradiated GSC7-2 gliomas near the site of MSC engraftment. CONCLUSIONS Administering IR to gliomas enhances MSC localization, particularly in GSCs that attract MSCs poorly at baseline. The chemokine CCL2 appears to play a crucial role in the IR-induced tropism of MSCs to gliomas.

Citing Articles

Mesenchymal stem cell transplantation plays a role in relieving cancer pain.

Zhang W, Chen D Front Pharmacol. 2024; 15:1483716.

PMID: 39679363 PMC: 11637888. DOI: 10.3389/fphar.2024.1483716.


Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression.

Zhang Y, Wang C, Li J Exp Hematol Oncol. 2024; 13(1):64.

PMID: 38951845 PMC: 11218091. DOI: 10.1186/s40164-024-00532-4.


The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma.

Wu Q, Berglund A, Macaulay R, Etame A Cells. 2024; 13(11.

PMID: 38891074 PMC: 11171993. DOI: 10.3390/cells13110942.


Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion.

De Fazio E, Pittarello M, Gans A, Ghosh B, Slika H, Alimonti P Int J Mol Sci. 2024; 25(5).

PMID: 38473812 PMC: 10932253. DOI: 10.3390/ijms25052563.


Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial Protocol.

Ramos-Fresnedo A, Al-Kharboosh R, Twohy E, Basil A, Szymkiewicz E, Zubair A Neurosurg Pract. 2024; 4(4).

PMID: 38464470 PMC: 10923529. DOI: 10.1227/neuprac.0000000000000062.


References
1.
Stracker T, Carson C, Weitzman M . Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature. 2002; 418(6895):348-52. DOI: 10.1038/nature00863. View

2.
Chen R, Nishimura M, Bumbaca S, Kharbanda S, Forrest W, Kasman I . A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell. 2010; 17(4):362-75. DOI: 10.1016/j.ccr.2009.12.049. View

3.
Leung S, Wong M, Chung L, Chan A, Yuen S . Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 1997; 93(5):518-27. DOI: 10.1007/s004010050647. View

4.
Xu F, Shi J, Yu B, Ni W, Wu X, Gu Z . Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro. Oncol Rep. 2010; 23(6):1561-7. DOI: 10.3892/or_00000796. View

5.
Fischer U, Harting M, Jimenez F, Monzon-Posadas W, Xue H, Savitz S . Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2008; 18(5):683-92. PMC: 3190292. DOI: 10.1089/scd.2008.0253. View